Home/Filings/4/0001144204-16-089615
4//SEC Filing

CorMedix Inc. 4

Accession 0001144204-16-089615

$CRMDCIK 0001410098operating

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 5:26 PM ET

Size

15.5 KB

Accession

0001144204-16-089615

Insider Transaction Report

Form 4
Period: 2016-02-12
Transactions
  • Award

    Phantom Stock

    2016-02-12+3,9683,968 total
    Common Stock (3,968 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $2.79Exp: 2024-02-27Common Stock (30,000 underlying)
    30,000
  • Stock Option (right to buy)

    Exercise: $2.11Exp: 2024-04-05Common Stock (15,000 underlying)
    15,000
  • Phantom Stock

    Common Stock (1,176 underlying)
    1,176
  • Phantom Stock

    Common Stock (3,125 underlying)
    3,125
  • Stock Option (right to buy)

    Exercise: $5.62Exp: 2025-03-01Common Stock (50,000 underlying)
    50,000
  • Phantom Stock

    Common Stock (1,847 underlying)
    1,847
  • Phantom Stock

    Common Stock (2,459 underlying)
    2,459
  • Stock Option (right to buy)

    Exercise: $1.91Exp: 2026-02-21Common Stock (90,000 underlying)
    90,000
Footnotes (4)
  • [F1]5,000 vest upon completion of an April 2014 milestone; 10,000 vest upon completion of another milestone by the third quarter of 2014.
  • [F2]These options vest in full on the first anniversary of the date of grant.
  • [F3]Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
  • [F4]These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of director fees.

Issuer

CorMedix Inc.

CIK 0001410098

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001410098

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:26 PM ET
Size
15.5 KB